miR-149 contributes to resistance of 5-FU in gastric cancer via targeting TREM2 and regulating β-catenin pathway

被引:14
|
作者
Wang, Xiao-yan [1 ]
Zhou, Yi-chan [3 ]
Wang, Yan [1 ]
Liu, Yun-yun [1 ]
Wang, Yu-xin [1 ]
Chen, Dan-dan [1 ]
Fan, Yu [2 ]
机构
[1] First Peoples Hosp Suqian, Dept Gastroenterol, Suqian 223800, Jiangsu, Peoples R China
[2] Jiangsu Univ, Canc Inst, Affiliated Peoples Hosp, Zhenjiang 212002, Jiangsu, Peoples R China
[3] Nanjing Med Univ, Dept Geriatr, Jiangsu Prov Key Lab Geriatr, Affiliated Hosp 1, Nanjing 210006, Jiangsu, Peoples R China
关键词
Drug resistance; Gastric cancer; miR-149; 5-FU; CISPLATIN RESISTANCE; MULTIDRUG-RESISTANCE; CELLS; PROLIFERATION; APOPTOSIS; MICRORNAS; REVERSES; BCL2;
D O I
10.1016/j.bbrc.2020.05.135
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Drug resistance remains the unresolved obstacle for gastric cancer (GC) treatment. Recently more and more studies have shown that microRNAs are involved in cancer resistance and could apply to drug resistance therapy in tumors. The relationship between miR-149 and 5-fluorouracil (5-FU) resistance in GC remains unclear. Here we detected miR-149 expression in 5-FU resistance tumor tissues and cell lines, and found that miR-149 expression is upregulated in AGS/5-FU cells compared with AGS cells. Further experiments indicated that overexpression of miR-149 can alleviate 5-FU-induced apoptosis and proliferation inhibition by targeting TREM2. It was also confirmed that TREM2 regulated 5-FU resistance through beta-catenin pathway. Generally speaking, our results indicated that miR-149 contributes to resistance of 5-FU in gastric cancer via targeting TREM2 and regulating beta-catenin pathway. (C) 2020 Published by Elsevier Inc.
引用
收藏
页码:329 / 335
页数:7
相关论文
共 50 条
  • [31] miR-149-5p promotes chemotherapeutic resistance in ovarian cancer via the inactivation of the Hippo signaling pathway
    Xu, Manman
    Xiao, Juan
    Chen, Ming
    Yuan, Linjing
    Li, Jundong
    Shen, Hongwei
    Yao, Shuzhong
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2018, 52 (03) : 815 - 827
  • [32] LncRNA ZEB2-AS1 contributes to the tumorigenesis of gastric cancer via activating the Wnt/β-catenin pathway
    Wang, Feixia
    Zhu, Wu
    Yang, Ruili
    Xie, Wanhua
    Wang, Daojun
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2019, 456 (1-2) : 73 - 83
  • [33] LncRNA ZEB2-AS1 contributes to the tumorigenesis of gastric cancer via activating the Wnt/β-catenin pathway
    Feixia Wang
    Wu Zhu
    Ruili Yang
    Wanhua Xie
    Daojun Wang
    Molecular and Cellular Biochemistry, 2019, 456 : 73 - 83
  • [34] MACC1 mediates chemotherapy sensitivity of 5-FU and cisplatin via regulating MCT1 expression in gastric cancer
    Wang, Chunlin
    Wen, Zhaowei
    Xie, Jianming
    Zhao, Yang
    Zhao, Liang
    Zhang, Shuyi
    Liu, Yajing
    Xue, Yan
    Shi, Min
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 485 (03) : 665 - 671
  • [35] Long non-coding RNA HNF1A-AS1 induces 5-FU resistance of gastric cancer through miR-30b-5p/EIF5A2 pathway
    Jiang, Lin
    Zhang, Yingjing
    Su, Pengfei
    Ma, Zhiqiang
    Ye, Xin
    Kang, Weiming
    Liu, Yuqin
    Yu, Jianchun
    TRANSLATIONAL ONCOLOGY, 2022, 18
  • [36] miR-20b reduces 5-FU resistance by suppressing the ADAM9/EGFR signaling pathway in colon cancer
    Fu, Qiang
    Cheng, Jing
    Zhang, Jindai
    Zhang, Yonglei
    Chen, Xiaobing
    Luo, Suxia
    Xie, Jianguo
    ONCOLOGY REPORTS, 2017, 37 (01) : 123 - 130
  • [37] miR-329 regulates the sensitivity of 5-FU in chemotherapy of colorectal cancer by targeting E2F1
    Yin, Jie
    Shen, Xiping
    Li, Mei
    Ni, Fangying
    Xu, Li
    Lu, Hua
    ONCOLOGY LETTERS, 2018, 16 (03) : 3587 - 3592
  • [38] HOXA13 contributes to gastric carcinogenesis through DHRS2 interacting with MDM2 and confers 5-FU resistance by a p53-dependent pathway
    Han, Yang
    Song, Chenlong
    Wang, Jianying
    Tang, Huamei
    Peng, Zhihai
    Lu, Su
    MOLECULAR CARCINOGENESIS, 2018, 57 (06) : 722 - 734
  • [39] Knockdown of PHGDH potentiates 5-FU cytotoxicity in gastric cancer cells via the Bcl-2/Bax/caspase-3 signaling pathway
    Zhang, Yunli
    Yang, Litao
    Dai, Guangou
    Cao, Hu
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2018, 11 (12): : 5869 - 5876
  • [40] Circ_0039569 contributes to the paclitaxel resistance of endometrial cancer via targeting miR-1271-5p/PHF6 pathway
    Li, Jia
    Zhang, Zhidong
    Hu, Yuanjing
    Wei, Qing
    Shao, Xuecheng
    ANTI-CANCER DRUGS, 2022, 33 (09) : 883 - 892